Works by Boonruang, Jakkrapatara

Results: 3
    1

    No significant drug−drug interaction between oral TAF‐based PrEP and feminizing hormone therapy among transgender women in Thailand: the iFACT‐3 study.

    Published in:
    Journal of the International AIDS Society, 2025, v. 28, n. 5, p. 1, doi. 10.1002/jia2.26502
    By:
    • Hiransuthikul, Akarin;
    • Thammajaruk, Narukjaporn;
    • Kerr, Stephen;
    • Janamnuaysook, Rena;
    • Nonenoy, Siriporn;
    • Hongchookiat, Piranun;
    • Trichavaroj, Rapee;
    • Tawon, Yardpiroon;
    • Boonruang, Jakkrapatara;
    • Teeratakulpisarn, Nipat;
    • Cressey, Tim R.;
    • Anderson, Peter L.;
    • Phanuphak, Nittaya
    Publication type:
    Article
    2
    3

    Exploring potential drug−drug interactions between masculinizing hormone therapy and oral pre‐exposure prophylaxis (F/TDF and F/TAF) among transgender men (iMACT study): a randomized, open‐label pharmacokinetic study in Thailand.

    Published in:
    Journal of the International AIDS Society, 2025, v. 28, n. 4, p. 1, doi. 10.1002/jia2.26445
    By:
    • Hiransuthikul, Akarin;
    • Thammajaruk, Narukjaporn;
    • Kerr, Stephen;
    • Janamnuaysook, Rena;
    • Nonenoy, Siriporn;
    • Hongchookiat, Piranun;
    • Trichavaroj, Rapee;
    • Tawon, Yardpiroon;
    • Boonruang, Jakkrapatara;
    • Teeratakulpisarn, Nipat;
    • Cressey, Tim R.;
    • Anderson, Peter L.;
    • Phanuphak, Nittaya
    Publication type:
    Article